Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeThe Road to a Vaccine

      The Road to a Vaccine: How new COVID-19 outbreaks are impacting a global return to normal

      In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.


      In Episode 2, Ling talks with Dr. Francis Collins, Director, NIH, about the latest on treatments and vaccines. Also, Harvard’s Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins’ Dr. Tom Inglesby explains what the new data on spread means for people.
      RTAV: Season 2, Episode 2
      Nurse holding a bottle of a vaccine

      Lisa Ling

      Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.
      Remo Colarusso 2020

      Remo Colarusso

      Colarusso is Vice President, Janssen Supply Chain at Johnson & Johnson. In this role, he leads the global manufacturing and supply management of all Johnson & Johnson pharmaceutical brands.

      Francis Collins, M.D., Ph.D.

      Dr. Collins was appointed the 16th Director of the National Institutes of Health by Barack Obama and continues to serve under President Donald Trump. In this role, he oversees the work of the largest supporter of biomedical research in the world. The physician-geneticist is renowned for his landmark discoveries of disease genes and his leadership of the international Human Genome Project.
      Dr. Tom Inglesby _ RTAV guest

      Tom Inglesby, M.D.

      Dr. Inglesby is the Director of the Center for Health Security of the Johns Hopkins Bloomberg School of Public Health. The Center for Health Security is dedicated to protecting people’s health from the consequences of epidemics and disasters.
      Dr. Ashish Jha _ RTAV guest

      Ashish K. Jha, M.D., M.P.H.

      Dr. Jha is the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and Director of the Harvard Global Health Institute, as well as a practicing general internist and Professor of Medicine at Harvard Medical School. He leads national analysis of key issues around the COVID-19 pandemic, advising policy makers and elected officials at the state and federal level. In September, Dr. Jha will begin work as the Dean of the Brown University School of Public Health.

      Paul Stoffels, M.D.

      Dr. Stoffels is the Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. He spearheads the research and product pipeline by leading teams across all of the company’s sectors to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions.

      “I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment

      Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.